Entries by ESO-admin

ESJ Comment: Long-Term Outcome After Ischemic Stroke in Relation to Comorbidity

/in ,

Comment Authors: Filipa Dourado Sotero, Diana Aguiar de Sousa, Neurology Department, Hospital de Santa Maria, Lisbon, Portugal Original Article: Stefan Sennfält, Mats Pihlsgård, Jesper Petersson Bo Norrving and Teresa Ullberg, 2019; Long-term outcome after ischemic stroke in relation to comorbidity – An observational study from the Swedish Stroke Register (Riksstroke); European Stroke Journal; DOI: 10.1177/2396987319883154 […]

Stroke Care in Ukraine: Press conference held in advance of WSD2019

/in

Out of more than 500 wards that provide assistance to patients with acute stroke, more than half do not have the necessary equipment for diagnosis and treatment By: Yuriy Flomin Kyiv, October 10, 2019 – On the eve of World Stroke Day, representatives of the Ukrainian Parliament’s Committee on National Health, Medical Assistance and Health […]

ESJ Comment: Is hospital diagnostic coding accurate enough for big data research?

/in ,

Routinely collected administrative hospital diagnostic coding data are widely used for outcome audit and big data research, including studies on time-trends of stroke incidence and outcome. The results of these studies are therefore influenced by the accuracy of hospital coding. In particular, studies on temporal trends are biased by changes in coding quality over time. […]

Cortical-Striatal Disconnection After Parietal Stroke

/in ,

By Dr Barbara Casolla, MD, Univ. Lille, Inserm U1171, Degenerative and Vascular Cognitive Disorders, CHU Lille, Department of Neurology, France Twitter: @BarbaraCasolla Clinical vignette An 82 years old patient was referred to the Emergency Department for a sudden left hemiparesis associated with dysarthria. His past history and vascular risk factors included a triple aorto-coronary bypass, […]

Bulgarian National Congress in Neurosonology and Cerebral Hemodynamics

/in

Report to ESO from the 5th Bulgarian National Congress in Neurosonology and Cerebral Hemodynamics By Acad. Prof. EKATERINA TITIANOVA, MD, PhD, DSc, Head of the Clinic of Functional Diagnostics of Nervous System, Military Medical Academy – Sofia, Professor of Neurology and Head of Department, Medical Faculty of Sofia University “St. Kl. Ohridski”, Academician of the […]

The ESO Edinburgh Stroke Research Workshop

/in

The ESO Edinburgh Stroke Research Workshop: do you want to develop a stroke research question for a PhD or MD project? Author: Dr Tom Moullaali, twitter: @tom_moullaali Affiliations: Centre for Clinical Brain Sciences, University of Edinburgh; George Institute for Global Health, Sydney. Are you an aspiring stroke researcher? Do you want to answer an important […]

Market Launch of First Factor Xa Reversal Agent in European Countries

/in ,

by Antje Schmidt-Pogoda, Fachärztin für Neurologie, Klinik für Neurologie mit Institut für Translationale Neurologie, Universitätsklinikum Münster, Albert-Schweitzer-Campus 1, Gebäude A1, 48149 Münster In recent weeks, a phased launch of andexanet alfa (Ondexxyaâ) was started in Germany, Austria, the United Kingdom, the Netherlands, Sweden, Denmark and Finland. For stroke physicians, the market release of Andexanet alfa […]

ESO Committee Corner: Trials Alliance (ESOTA)

/in

ESOTA continues to develop and grow, now including over 200 participating hospitals in 6 countries. Member stroke research networks include Netherlands (CONTRAST), Stroke Trials Network Ireland, the UK Clinical Research Network, Swiss Stroke Trials Network, Spanish Stroke Society Network, and Scotland Stroke Research Network. Up to 6 more countries are expected to join by 2021. […]